ZA935660B - Modified proteases. - Google Patents
Modified proteases.Info
- Publication number
- ZA935660B ZA935660B ZA935660A ZA935660A ZA935660B ZA 935660 B ZA935660 B ZA 935660B ZA 935660 A ZA935660 A ZA 935660A ZA 935660 A ZA935660 A ZA 935660A ZA 935660 B ZA935660 B ZA 935660B
- Authority
- ZA
- South Africa
- Prior art keywords
- pct
- modified
- date feb
- proteases
- sec
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6435—Plasmin (3.4.21.7), i.e. fibrinolysin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6456—Plasminogen activators
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21007—Plasmin (3.4.21.7), i.e. fibrinolysin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB929216558A GB9216558D0 (en) | 1992-08-04 | 1992-08-04 | Modified proteases |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA935660B true ZA935660B (en) | 1994-03-17 |
Family
ID=10719807
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA935660A ZA935660B (en) | 1992-08-04 | 1993-08-14 | Modified proteases. |
Country Status (10)
Country | Link |
---|---|
US (2) | US5645833A (de) |
EP (1) | EP0658206B1 (de) |
JP (1) | JP3449717B2 (de) |
AT (1) | ATE282089T1 (de) |
AU (1) | AU4720093A (de) |
DE (1) | DE69333689T2 (de) |
ES (1) | ES2232812T3 (de) |
GB (1) | GB9216558D0 (de) |
WO (1) | WO1994003614A1 (de) |
ZA (1) | ZA935660B (de) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU7278094A (en) * | 1994-06-07 | 1996-01-04 | M D Serv Europe S.A. | Intravasal thrombolysis |
GB9412131D0 (en) * | 1994-06-17 | 1994-08-10 | British Bio Technology | Thrombolytic composition |
US6942978B1 (en) * | 1999-03-03 | 2005-09-13 | The Board Of Trustees Of The University Of Arkansas | Transmembrane serine protease overexpressed in ovarian carcinoma and uses thereof |
US7700341B2 (en) * | 2000-02-03 | 2010-04-20 | Dendreon Corporation | Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon |
JP2001275677A (ja) * | 2000-03-30 | 2001-10-09 | Canon Inc | 核酸断片プライマーまたはプローブ、およびこれを用いたポリヒドロキシアルカノエート合成微生物の検出方法 |
EP1390497A2 (de) | 2001-05-25 | 2004-02-25 | Genset | Menschliche cdns und proteine und verwendungen davon |
DE102006053404A1 (de) * | 2006-11-10 | 2008-05-15 | Hydro Aluminium Alucast Gmbh | Gießform zum Gießen eines Gussteils und Verwendung einer solchen Gießform |
JP2018537976A (ja) * | 2015-11-25 | 2018-12-27 | アカデミシュ・ジークンホイス・ライデン | 組換えセリンプロテアーゼ |
US11613744B2 (en) | 2018-12-28 | 2023-03-28 | Vertex Pharmaceuticals Incorporated | Modified urokinase-type plasminogen activator polypeptides and methods of use |
EP3902913A1 (de) | 2018-12-28 | 2021-11-03 | Catalyst Biosciences, Inc. | Modifizierte urokinaseartige plasminogenaktivatorpolypeptide und verfahren zur verwendung |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2007364A1 (en) * | 1989-01-17 | 1990-07-17 | David J. Livingston | Gene sequences encoding modified residues situated in the protease domain of tpa |
US5304482A (en) * | 1989-03-06 | 1994-04-19 | The Board Of Regents Of The University Of Texas System | Serine protease mutants of the chymotrypsin superfamily resistant to inhibition by their cognate inhibitors |
EP1029921B1 (de) * | 1989-03-06 | 2002-10-23 | The Board of Regents of The University of Texas System | Serpin-resistenter T-PA; Mutanten; Gene |
GB8927722D0 (en) * | 1989-12-07 | 1990-02-07 | British Bio Technology | Proteins and nucleic acids |
-
1992
- 1992-08-04 GB GB929216558A patent/GB9216558D0/en active Pending
-
1993
- 1993-08-03 JP JP50511494A patent/JP3449717B2/ja not_active Expired - Lifetime
- 1993-08-03 EP EP93917972A patent/EP0658206B1/de not_active Expired - Lifetime
- 1993-08-03 ES ES93917972T patent/ES2232812T3/es not_active Expired - Lifetime
- 1993-08-03 AT AT93917972T patent/ATE282089T1/de not_active IP Right Cessation
- 1993-08-03 US US08/379,621 patent/US5645833A/en not_active Expired - Lifetime
- 1993-08-03 AU AU47200/93A patent/AU4720093A/en not_active Abandoned
- 1993-08-03 DE DE69333689T patent/DE69333689T2/de not_active Expired - Lifetime
- 1993-08-03 WO PCT/GB1993/001632 patent/WO1994003614A1/en active IP Right Grant
- 1993-08-14 ZA ZA935660A patent/ZA935660B/xx unknown
-
1997
- 1997-07-07 US US08/889,078 patent/US5932213A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
DE69333689D1 (de) | 2004-12-16 |
GB9216558D0 (en) | 1992-09-16 |
JPH07509610A (ja) | 1995-10-26 |
AU4720093A (en) | 1994-03-03 |
ATE282089T1 (de) | 2004-11-15 |
US5932213A (en) | 1999-08-03 |
WO1994003614A1 (en) | 1994-02-17 |
EP0658206B1 (de) | 2004-11-10 |
DE69333689T2 (de) | 2005-11-03 |
JP3449717B2 (ja) | 2003-09-22 |
EP0658206A1 (de) | 1995-06-21 |
US5645833A (en) | 1997-07-08 |
ES2232812T3 (es) | 2005-06-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX9709915A (es) | Heterociclos de peptidilo y composiciones que los contienen, utiles en el tratamiento de trastornos relacionados con trombina, y uso de los mismos. | |
DE69533472D1 (de) | Kallikreinhemmende "kunitz-domäne"-proteine und derivaten davon | |
DE69033699D1 (de) | Gegenüber eigenen inhibitoren resistente t-pa mutanten | |
EP0072947A3 (en) | Agent for the prevention and treatment of liver and kidney diseases | |
GB9216558D0 (en) | Modified proteases | |
MX9701514A (es) | Limpieza, desinfeccion y preparacion de lentes de contacto. | |
WO1996024650A3 (en) | Cytoplasmic antiproteinase-2 and cytoplasmic antiproteinase-3 and coding sequences | |
HUT70215A (en) | Thrombin inhibitors | |
DE69319337D1 (en) | Polyetheramidoamine hydrogele als heparinersatz | |
ES2133328T3 (es) | Enzimas de detergente de verticillium. | |
FI951078A0 (fi) | Retrovirusinfektion inhibitio | |
GR3024267T3 (en) | Cytotoxic t-lymphocyte antigen as cysteine protease inhibitor. | |
MXPA03010380A (es) | Uso de inhibidores de la proteasa para el virus de inmunodeficiencia humana (vih) para bloquear la migracion y/o invasion de celulas, infiltracion de tejido y formacion de edema. | |
ES2080657A1 (es) | Proteasas modificadas. | |
BR9608978A (pt) | Inibidor de protease de serina derivado de imidazo [1,5a] piridina composição farmacêutica e utilização do inibidor de protease | |
TW288046B (en) | Nucleotide sequence of cDNA of a thrombin-like enzyme (ancrod) from Calloselasma rhodostoma and amino acid sequence of ancrod therefrom | |
FR2657005B1 (fr) | Systeme d'enclouage pour le traitement des fractures notamment du type cervico-trochanteriennes et pertrochanteriennes. | |
SI0828483T1 (en) | Use of tropolone derivatives as inhibitors of the enzyme inositol monophosphatase | |
DE59813159D1 (de) | Kombination der proteolytischen enzyme trypsin, bromelain und papain zur behandlung von glomerulonephritis | |
DE69319140D1 (de) | 4-guanidinobutyramid zur verbesserung des blutkreislaufs |